The Maria Sklodowska-Curie National Research Institute of Oncology

Statistics

Publications

11.2K

Citations

834.5K

Authors

1.3K

Location

Warsaw, Poland

Also known as Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie · Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology · Marii Skłodowskiej-Curie Państwowy Instytut Badawczy · Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy · Radium Institute

The Maria Sklodowska-Curie National Research Institute of Oncology is a healthcare institution in Warsaw, Poland known for oncology, medicine, and molecular oncology.

Homepage Wikipedia ROR

Top concepts

MedicineOncologyMolecular OncologyLife SciencesGeneticsMalignant NeoplasmsCancer GeneticsRadiation TherapyNeoplasiaSurgery

Publications

11.2K

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa et al. · Journal of Extracellular Vesicles · 2018 · 11.2K citations · Full text

Life Sciences, Cell Biology, Physiology +13

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp et al. · The Lancet · 2016 · 4.8K citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 11.2K

Authors

1.3K

JL
Jolanta Lissowska
The Maria Sklodowska-Curie National Research Institute of Oncology, Poland
747 publications · 65.1K citations
115
h-index
PR
Piotr Rutkowski
The Maria Sklodowska-Curie National Research Institute of Oncology, Poland
1.5K publications · 83.9K citations
111
h-index
BJ
Barbara Jarząb
The Maria Sklodowska-Curie National Research Institute of Oncology, Poland
468 publications · 20.6K citations
67
h-index
WZ
Witold Zatoński
The Maria Sklodowska-Curie National Research Institute of Oncology, Poland
448 publications · 20K citations
64
h-index
WJ
Wojciech Jurczak
The Maria Sklodowska-Curie National Research Institute of Oncology, Poland
648 publications · 21.5K citations
58
h-index

1–5 of 1.3K